MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial

por Romano, Emanuela, Michielin, Olivier, Voelter, Verena, Laurent, Julien, Bichat, Hélène, Stravodimou, Athina, Romero, Pedro, Speiser, Daniel E, Triebel, Frédéric, Leyvraz, Serge, Harari, Alexandre
Publicado 2014

FcgRIIIA (CD16)-expressing monocytes mediate the depletion of tumor-infiltrating Tregs via Ipilimumab-dependent ADCC in melanoma patients

por Romano, Emanuela, Kusio-Kobialka, Monika, Foukas, Periklis G, Bichat, Helene, Baumgaertner, Petra, Meyer, Christiane, Ballabeni, Pierluigi, Michielin, Olivier, Weide, Benjamin, Romero, Pedro, Speiser, Daniel E
Publicado 2014